No Data
After accumulating Hepalink (09989) for two consecutive months, will Southbound capital via the Stock Connect be poised to benefit from a reversal in the heparin cycle?
Since the second quarter of this year, Hepalink's (09989 HK) share price has continued to decline, with a drop of nearly 20% over the period. Behind this sustained downward trend, pricing pressures in the heparin industry chain and overseas policy risks have become key factors driving capital outflows from the market.
Shenzhen Hepalink Sets Final 2025 Dividend and Updated Payment Date
Hepalink will pay a final dividend of HK$1.6604 per 10 shares on July 22.
Hepalink (09989) announced that it will pay a final dividend of HK$1.6604 per 10 shares for the year ended December 31, 2025, on July 22, 2026.
Express News | Ministry of Commerce Holds Roundtable Meeting with Foreign-Invested Enterprises in the Pharmaceutical Industry
Hepalink Pharma Names New Employee Representative Director as Board Term Renews
Hepalink Shareholders Back All Resolutions at 2025 AGM